Status:

COMPLETED

The Effect of Obesity on Contralateral Suppression in Patients With Multiple Sclerosis

Lead Sponsor:

Ondokuz Mayıs University

Conditions:

Multiple Sclerosis

Obesity

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

This study investigates how obesity may affect the auditory system in individuals with Multiple Sclerosis (MS). Specifically, it examines the brain's ability to process and suppress sounds (contralate...

Detailed Description

This study investigates the potential impact of obesity on auditory efferent system function in individuals diagnosed with Multiple Sclerosis (MS). Specifically, it focuses on assessing contralateral ...

Eligibility Criteria

Inclusion

  • Eligibility Criteria Minimum Age: 18 Years Maximum Age: 50 Years Sex: All Gender Based: No Accepts Healthy Volunteers: No
  • Ability to cooperate with the applied scales and auditory tests
  • Normal findings in otoscopic examination (ear, nose, and throat evaluation)
  • Absence of any neurological, psychiatric, or metabolic disease other than Multiple Sclerosis (MS)
  • No history of significant noise exposure
  • For female participants: not pregnant and not in the menstrual period

Exclusion

  • Presence of active middle ear pathology (e.g., otitis media, tympanic membrane perforation)
  • Abnormal tympanometric findings
  • Hearing loss exceeding 20 dB HL at any frequency between 500-4000 Hz
  • Neurological or psychiatric disorders other than MS
  • History of ear surgery or otologic trauma
  • Use of medications known to affect auditory function (e.g., ototoxic drugs)
  • Inability to cooperate with audiological testing
  • Pregnancy
  • Diagnosis of metabolic or endocrine disorders (e.g., uncontrolled diabetes, thyroid dysfunction)
  • Body Mass Index (BMI) below 18.5 (underweight) or above 40 (morbid obesity)

Key Trial Info

Start Date :

June 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2025

Estimated Enrollment :

49 Patients enrolled

Trial Details

Trial ID

NCT07136311

Start Date

June 1 2022

End Date

June 30 2025

Last Update

August 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ondokuz Mayıs University

Samsun, Turkey (Türkiye), 55000